Amit Mahipal

Amit Mahipal practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Amit Mahipal's NPI, 1417148180, was assigned on August 7, 2007. Amit Mahipal holds Minnesota license 60080.

Amit Mahipal's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Amit Mahipal's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Amit Mahipal is also affiliated with University Hospitals Ahuja Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Amit Mahipal to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amit Mahipal practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Amit Mahipal's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Amit Mahipal's licenses on file in 2 states: Minnesota and Florida.

CMS data shows 191 Medicare services from Amit Mahipal across 3 procedure codes in 2024, all of them office visits, for 85 Medicare patients. Medicare paid $17,000 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Amit Mahipal in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amit Mahipal's median patient age at 70, with 43% women.

In 2024, Amit Mahipal wrote 564 Medicare Part D claims for 83 patients. 85% of them were for generic drugs. CMS names the drug for 435 of them, across 12 drugs with 11 or more claims each, at $780,783 in total drug cost. In 2023, CMS named 183 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Amit Mahipal for performance year 2024, reported as part of a group. Amit Mahipal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amit Mahipal as offering telehealth.

CMS Open Payments shows 701 general payments to Amit Mahipal from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. AstraZeneca Pharmaceuticals LP paid the most, $271,977. It also lists 7 research payments totaling $2,921 from 2020 to 2025.